Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome

MYPI2025003243A0Undetermined Publication Date: 2021-12-05NOEMA PHARMA AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003243
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-03-12
Filing Date
2021-06-04
Publication Date
2021-12-05
Patent Text Reader

Abstract

Provided herein are methods of treating Tourette Syndrome in a subject in need thereof by administering to the subject compositions comprising a PDE10 inhibitor of Formula (I). Also disclosed are crystalline solid forms of the compound of Formula (I) and uses thereof. (FORMULA 1) (NO SUITABLE FIGURE)
Need to check novelty before this filing date? Find Prior Art